Ignite Creation Date:
2025-12-24 @ 7:07 PM
Ignite Modification Date:
2026-04-12 @ 10:08 PM
Study NCT ID:
NCT00909857
Status:
COMPLETED
Last Update Posted:
2015-08-24
First Post:
2009-04-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Effect on Primary Dysmenorrhea
Sponsor:
Bayer
Organization:
Study Overview
Official Title:
A Multi-center, Double-blind, Double-dummy, Randomized, Controlled, Parallel-group Study to Assess Efficacy and Safety of SH T00658ID Compared to SH D593B in the Treatment of Primary Dysmenorrhea
Status:
COMPLETED
Status Verified Date:
2015-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate the potential benefits of a new oral contraceptive (SH T00658ID) on alleviating complaints of dysmenorrhea associated with oral contraceptive use.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: